RAC 2.20% $1.78 race oncology ltd

Ann: RC220 Meets Quality Specifications, page-4

  1. 926 Posts.
    lightbulb Created with Sketch. 1096
    Further de-risking & progress towards administering Bisantrene in patients veins !
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.